More than that, hnRNPA1 was demonstrated to be concerned in mediating PCa enzalutamide (Enz) sensitivity via lnc-OPHN1-5/AR interaction [63], promoting triple-negative breast cancer (TNBC) progression via competitively binding to lncRNA HYOU1-AS [64], sustaining activation of NF-κB pathway in PDAC via lncRNA-PLACT1/IκBα/E2F1 feedback loop [65], and regulating ovarian cancer (OC) chemoresistance via miR-18a-KRAS axis [66]. This evidence concerns the gene AR and posterior cortical atrophy.